Cited by 1,1723D Printing in Biomedical ResearchCancer Cells and MetastasisNanoparticle-Based Drug Delivery

Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy

Open access
Mehta, Geeta, Hsiao, Amy Y., Ingram, Marylou, Luker, Gary D., Takayama, Shuichi·2012·Journal of Controlled Release

Abstract

Multicellular spheroids are three dimensional in vitro microscale tissue analogs. The current article examines the suitability of spheroids as an in vitro platform for testing drug delivery systems. Spheroids model critical physiologic parameters present in vivo, including complex multicellular architecture, barriers to mass transport, and extracellular matrix deposition. Relative to two-dimensional cultures, spheroids also provide better target cells for drug testing and are appropriate in vitro models for studies of drug penetration. Key challenges associated with creation of uniformly sized spheroids, spheroids with small number of cells and co-culture spheroids are emphasized in the article. Moreover, the assay techniques required for the characterization of drug delivery and efficacy in spheroids and the challenges associated with such studies are discussed. Examples for the use of spheroids in drug delivery and testing are also emphasized. By addressing these challenges with possible solutions, multicellular spheroids are becoming an increasingly useful in vitro tool for drug screening and delivery to pathological tissues and organs.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2012.04.045

Cites

158 of 158 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cells in the intermediate zone of a spheroid are often senescent.

    “cells located in the intermediate zone are often senescent”

    From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [184]

    In the Introduction section “Spheroids as appropriate models for drug delivery” (page not available), the paper describes the layer between the necrotic core and proliferating outer rim as quiescent, not senescent. Quiescence and senescence are distinct cellular states; the cited passage does not support substituting one for the other. (LLM, conf=0.83)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • Inclusion of spheroids within ECM contributes to better reproducing tumor-specific hallmarks.

    “Emerging evidence has demonstrated that the inclusion of spheroids within ECM contributes to better reproducing of tumor‐specific hallmarks.[ 62 ]”

    From 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip (2023) · cites this paper as [62]

    In the Introduction’s “Challenge 3” section (page not provided), the paper says spheroids can integrate ECM and that capturing microenvironmental interactions helps make 3-D models more faithful to tissue. It does not specifically show that embedding spheroids within ECM improves reproduction of tumor-specific hallmarks; the reported improvement in modeling tumor progression concerns co-culture with endothelial cells. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Hanging drop methods have high reliability and reproducibility but fluid volume is limited and the method is not good for long-term culture due to difficulty in refreshing the culture medium.

    “It has high reliability and reproducibility but fluid volume is limited and the method is not good for long-term culture due to difficulty in refreshing the culture medium [58,75].”

    From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [58]

    In ‘Challenge 1: Forming and maintaining spheroids of uniform size’ (page not provided), the paper says conventional hanging drops allow defined spheroid size but that changing medium is time-consuming, supporting the culture-maintenance concern. It describes 15–20 μl drops in a particular plate, not a general fluid-volume limit, and does not establish high reliability for hanging-drop methods generally. It also reports that an improved hanging-drop plate enables long-term culture, so the limitation needs to be qualified as applying to conventional methods. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Spheroids exhibit spatially organized regions of proliferation, quiescence, and hypoxia.

    “Spheroids exhibit spatially organized regions of proliferation, quiescence, and hypoxia, and can incorporate non-tumor cells to mimic tumor–stroma crosstalk.”
  • Cells in the outermost layer of a spheroid are typically highly proliferative due to proximity to nutrients and oxygen.

    “Cells in the outermost layer of the spheroid are typically highly proliferative due to their proximity to nutrients and oxygen.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [114]Saltzman WM Drug Delivery: Engineering Principles for Drug Therapy Oxford University Press New York 2001

Cited by

Sorted by citations

Authors
Mehta, G., Hsiao, A. Y., Ingram, M., Luker, G. D., & Takayama, S.
Affiliations
  • University of Michigan (US)
  • Huntington Medical Research Institutes (US)
Corresponding author
  • Mehta, Geeta
  • Takayama, Shuichi
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
2012-12
Volume
164
Issue
2
Pages
192-204
ISSN
0168-3659 (ISSN-L)
OpenAlex
W2105017561
Cited by
1,172
References
158
Citations by year
2026: 56 · 2025: 76 · 2024: 84 · 2023: 87 · 2022: 93 · 2021: 108 · 2020: 125 · 2019: 99 · 2018: 102 · 2017: 113 · 2016: 86 · 2015: 61 · 2014: 52 · 2013: 27 · 2012: 3
FWCI
26.08
Type
journal article
Language
en
Open access
Locations
  • Journal of Controlled Release (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Scholarworks@UNIST (Ulsan National Institute of Science and Technology) (submittedVersion)
Funders
National Cancer Institute (R01CA136829, R01CA136553, P50CA093990, P30CA046592)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
tumor spheroids, 3D cell culture, drug delivery systems, drug penetration, drug efficacy testing, in vitro drug testing, extracellular matrix deposition, co-culture spheroids, drug screening assay
MeSH terms
Animals, Antineoplastic Agents, Disease Models, Animal, Humans, Neoplasms, Tumor Cells, Cultured, Drug Delivery Systems, Treatment Outcome, Spheroids, Cellular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review